Dry AMD Symposium 1

Related

• 

  Baseline Characteristics in the Phase 2 GOLDEN Study of IONIS-FB-LRx, an Investigational Antisense Oligonucleotide Designed to Treat AMD-Associated Geographic Atrophy

  Glenn J. Jaffe, MD

  Annual Meeting Talks

  2022

• 

  Pegcetacoplan Safety: Panel Recap

  Andre J. Witkin, MD

  Updates from the Field

  2024

• 

  Episode 19: LEAD Trial for Use of Nanopulse Laser for Dry AMD with Dr. Robyn Guymer

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2018